Farletuzumab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Farletuzumab, covering 2013-11-04 to 2022-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse [Phase 3]